Hyperhomocysteinemia and the methylenetetrahydrofolate reductase 677C-T mutation in patients under 50 years of age affected by central retinal vein occlusion

Ophthalmology

Volumn 111, Issue 5, 2004, Pages 940-945

  Di Crecchio, Lorenzo ^a   Parodi, Maurizio Battaglia ^a   Sanguinetti, Giorgia ^a   Iacono, Pierluigi ^a   Ravalico, Giuseppe ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HOMOCYSTEINE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; CENTRAL RETINA ARTERY OCCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLUORESCENCE ANALYSIS; GENE MUTATION; GENETIC ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMOZYGOSITY; HUMAN; HYPERHOMOCYSTEINEMIA; LABORATORY TEST; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HOMOCYSTEINE; HOMOZYGOTE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POINT MUTATION; PROSPECTIVE STUDIES; RETINAL VEIN OCCLUSION; RISK FACTORS;

EID: 2342642890     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2003.08.028     Document Type: Article

References (31)

1. Fong A.C., Schatz H. Central retinal vein occlusion in young adults. Surv Ophthalmol. 37:1993;393-417
2. Kluijtmans L.A., Kastelein J.J., Lindemans J., et al. Thermolabile methylenetetrahydrofolate reductase in coronary artery disease. Circulation. 96:1997;2573-2577
3. Harmon D.L., Doyle R.M., Meleady R., et al. Genetic analysis of the thermolabile variant of 5, 10-methylenetetrahydrofolate reductase as a risk factor for ischemic stroke. Arterioscler Thromb Vasc Biol. 19:1999;208-211
4. Arruda V.R., von Zuben P.M., Chiaparini L.C., et al. The mutation Ala677→Val in the methylene tetrahydrofolate reductase gene a risk factor for arterial disease and venous thrombosis. Thromb Haemost. 77:1997;818-821
5. Welch G.N., Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med. 338:1998;1042-1050
6. Selhub J., Jacques P.F., Wilson P.W., et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 270:1993;2693-2698
7. Tucker K.L., Selhub J., Wilson P.W., Rosenberg I.H. Dietary intake pattern relates to plasma folate and homocysteine concentrations in the Framingham Heart Study. J Nutr. 126:1996;3025-3031
8. Nygård O., Refsum H., Ueland P.M., Vollset S.E. Major lifestyle determinants of plasma total homocysteine distribution the Hordaland Homocysteine Study. Am J Clin Nutr. 67:1998;263-270
9. Jacques P.F., Bostom A.G., Wilson P.W., et al. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr. 73:2001;613-621
10. Kang S.S., Wong P.W., Susmano A., et al. Thermolabile methylenetetrahydrofolate reductase an inherited risk factor for coronary artery disease. Am J Hum Genet. 48:1991;536-545
11. Frosst P., Blom H.J., Milos R., et al. A candidate genetic risk factor for vascular disease a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 10:1995;111-113
12. Selhub J. Homocystine metabolism. Annu Rev Nutr. 19:1999;217-246
13. Desouza C., Keebler M., McNamara D.B., Fonseca V. Drugs affecting homocysteine metabolism impact on cardiovascular risk. Drugs. 62:2002;605-616
14. Verrotti A., Pascarella R., Trotta D., et al. Hyperhomocysteinemia in children treated with sodium valproate and carbamazepine. Epilepsy Res. 41:2000;253-257
15. Giral P., Bruckert E., Jacob N., et al. Homocysteine and lipid lowering agents. A comparison between atorvastatin and fenofibrate in patients with mixed hyperlipidemia. Atherosclerosis. 154:2001;421-427
16. Larsson J., Hultberg B., Hillarp A. Hyperhomocysteinemia and the MTHFR C677T mutation in central retinal vein occlusion. Acta Ophthalmol Scand. 78:2000;340-343
17. The Eye Disease Case-Control Study Group. Risk factors for central retinal vein occlusion. Arch Ophthalmol. 114:1996;545-554
18. Loewenstein A., Goldstein M., Winder A., et al. Retinal vein occlusion associated with methylenetetrahydrofolate reductase mutation. Ophthalmology. 106:1999;1817-1820
19. Pianka P., Almog Y., Man O., et al. Hyperhomocystinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion. Ophthalmology. 107:2000;1588-1592
20. Vine A.K. Hyperhomocysteinemia a risk factor for central retinal vein occlusion. Am J Ophthalmol. 129:2000;640-644
21. Hansen L., Kristensen H.L., Bek T., Ingerslev J. Markers of thrombophilia in retinal vein thrombosis. Acta Ophthalmol Scand. 78:2000;523-526
22. Cahill M., Karabatzaki M., Meleady R., et al. Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease. Br J Ophthalmol. 84:2000;154-157
23. Cahill M., Karabatzaki M., Donoghue C., et al. Thermolabile MTHFR genotype and retinal vascular occlusive disease. Br J Ophthalmol. 85:2001;88-90
24. Lahey J.M., Tunç M., Kearney J., et al. Laboratory evaluation of hypercoagulable states in patients with central retinal vein occlusion who are less than 56 years of age. Ophthalmology. 109:2002;126-131
25. Brown B.A., Marx J.L., Ward T.P., et al. Homocysteine a risk factor for retinal venous occlusive disease. Ophthalmology. 109:2002;287-290
26. Weger M., Stanger O., Deutschmann H., et al. Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 240:2002;286-290
27. Knekt P., Reunanen A., Alfthan G., et al. Hyperhomocysteinemia a risk factor or a consequence of coronary heart disease? Arch Intern Med. 161:2001;1589-1594
28. Christen W.G., Ajani U.A., Glynn R.J., Hennekens C.H. Blood levels of homocysteine and increased risks of cardiovascular disease causal or casual? Arch Intern Med. 160:2000;422-434
29. Dudman N.P. An alternative view of homocysteine. Lancet. 354:1999;2072-2074
30. Egerton W., Silberberg J., Crooks R., et al. Serial measures of plasma homocyst(e)ine after acute myocardial infarction. Am J Cardiol. 77:1996;759-761
31. Lindgren A., Brattstrom L.E., Norrving B., et al. Plasma homocysteine in the acute and convalescent phases after stroke. Stroke. 26:1995;795-800